摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-dihydro-5,7-diphenyl-1,4-diazepinium perchlorate | 22123-86-0

中文名称
——
中文别名
——
英文名称
2,3-dihydro-5,7-diphenyl-1,4-diazepinium perchlorate
英文别名
5,7-diphenyl-2,3-dihydro-1,4-diazepinium perchlorate;5,7-diiphenyl-2,3-dihydro-1,4-diazepinium perchlorate;2,3-Dihydro-5,7-diphenyl-1H-1,4-diazepinium-perchlorat;5,7-diphenyl-2,3-dihydro-1H-1,4-diazepine;perchloric acid
2,3-dihydro-5,7-diphenyl-1,4-diazepinium perchlorate化学式
CAS
22123-86-0
化学式
C17H16N2*ClHO4
mdl
——
分子量
348.786
InChiKey
NPOVLOBOLRPKJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

点击查看最新优质反应信息

文献信息

  • Vinamidinium-Salze als Nucleophile Vinamidinium Salts as Nucleophiles
    作者:H. Möhrle、U. von der Lieck-Waldheim
    DOI:10.1515/znb-1996-0319
    日期:1996.3.1
    Abstract

    2,3-Dihydro-1,4-diazepinium salts could not be aminomethylated with conventional methods, but the hydrochlorides produced with methyleniminium salts the C-Mannich-compounds. The reactivity of the substrate was mainly controlled by electronic effects of the substituents. Aminomethylation of 1,5-diazapentadienium salts occurred only if the conformations caused no steric hindrance of the β-C-atom. Methyl substituted 2,3-dihydro-1,4-diazepinium salts reacted with 1,3,5 triazine to pyrimidine anellated derivatives.

    摘要:2,3-二氢-1,4-二氮杂环盐无法通过常规方法进行甲基化,但使用亚甲基亚胺盐生成了化物,即C-Mannich-化合物。底物的反应性主要受取代基的电子效应控制。只有当1,5-二氮杂戊二烯盐的构象不造成β-C-原子的立体位阻时,才会发生甲基化反应。甲基取代的2,3-二氢-1,4-二氮杂环盐与1,3,5-三嗪反应生成嘧啶环并联衍生物
  • Electrochemical reduction of the 5,7-diphenyl-2,3-dihydro-1,4-diazepinium cation
    作者:Douglas Lloyd、Colin A. Vincent、David J. Walton
    DOI:10.1039/p29800000668
    日期:——
    The 5,7-diphenyl-2,3-dihydro-1,4-diazepinium cation (II), dissolved in dimethylformamide, is reduced in two steps. The first wave, at –1.23 V with respect to an aqueous Ag–AgCl–KCl (saturated) reference, provides a radical which disproportionates to give the corresponding dihydrodiazepine base (I) and a tetrahydrodiazepine (IV). The second wave is at –2.00 V and produces the anion (IV). The reduction
    溶解在二甲基甲酰胺中的5,7-二苯基-2,3-二氢-1,4-二氮杂吡啶鎓阳离子(II)分两步还原。相对于性Ag-AgCl-KCl(饱和)参比,在–1.23 V处的第一波提供了不成比例的自由基,从而给出了相应的二氢二氮杂base碱(I)和四氢二氮杂((IV)。第二个波为–2.00 V,并产生阴离子(IV)。通过极谱法,循环伏安法和制备型电化学方法研究了还原反应。二氢二氮杂base碱在–2.1 V时无电活性,在该处显示出明显的两电子还原波。
  • Calsy, Adrianne; King, James; Lloyd, Douglas, Liebigs Annalen der Chemie, 1986, # 8, p. 1387 - 1392
    作者:Calsy, Adrianne、King, James、Lloyd, Douglas、Reichardt, Christian、Struthers Margot
    DOI:——
    日期:——
  • CALSY A.; KING J.; LLOYD D.; REICHARDT CH.; STRUTHERS M., LIEBIGS ANN. CHEM.,(1986) N 8, 1387-1392
    作者:CALSY A.、 KING J.、 LLOYD D.、 REICHARDT CH.、 STRUTHERS M.
    DOI:——
    日期:——
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 5,7-二甲基-2,3,5,6-四氢-1H-环戊二烯并[b]吡嗪 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5-甲基-7-三氟甲基-1H-1,4-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 8-Phenyl-2,3,6,7-tetrahydro-4H-1,4-diazocin-5-on 1,3-diphenyl-1,2-dihydro-pyridazino[3,4-b]quinoxaline 3-(4-Bromphenyl)-5,6,7,8-tetrahydro-thiazolo<3,2-a>-<1,3>diazepin 2,3-Dihydro-5-methyl-1,4-diazepin 3-Methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a][1,3]diazepine 2,4,10,12,18,20-hexamethyl-1,5,9,13,17,21-hexaaza-cyclotetracosa-1,3,9,11,17,19-hexaene 2-(2-benzylidene-3-((4-methylbenzylidene)hydrazineylidene)-2,3,6,7,8,9-hexahydro-5H-thiazolo[2,3-b]quinazolin-5-yl)phenol 3,11-diphenyl-1,5,9,13-tetraaza-cyclohexadeca-1,3,9,11-tetraene 7,10-dichloro-4-[4-(1,1-difluoroethyl)phenyl]-5,6-dihydro-4H-pyrrolo[1,2-a][1,4]-benzodiazepine hydrochloride 7-bromo-5,6-dihydro-2,3-dimethylpyrido<2,3-b>pyrazine 7-(3-Chloro-4-fluoro-phenyl)-5-trifluoromethyl-2,3-dihydro-1H-[1,4]diazepine 6,14-diphenyl-1,4,8,12-tetraaza-cyclopentadeca-4,6,12,14-tetraene 6,13-diphenyl-1,4,8,11-tetraaza-cyclotetradeca-4,6,11,13-tetraene 7-(3-Chloro-4-fluoro-phenyl)-5-phenyl-2,3-dihydro-1H-[1,4]diazepine 7-(4-Fluoro-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine 3-(7-methyl-5-oxo-4,5-dihydro-2H-pyrazolo[1,5-a]pyrimidin-1-yl)-but-2-enenitrile 7-(2-Fluoro-5-methyl-phenyl)-5-methyl-2,3-dihydro-1H-[1,4]diazepine trans-diazido(2,3,9,10-tetramethyl-1,4,8,11-tetra-azacyclotetradeca-1,3,8,10-tetraene)cobalt(III) perchlorate 2,2-dimethyl-2,6,7,8-tetrahydro-3H-pyrrolo[1,2-a]pyrimidin-4-one ethyl 4-acetamidodiazepine-1-carboxylate 5,7-dimethyl-4,5,6,7-tetrahydro-1H-[1,4]diazepine-2,3-dicarbonitrile 1,4,8,11-Tetraazacyclotetradeca-4,6,11,13-tetraene,5,7,12,14-tetramethyl- 5,6,6,7a-tetramethyl-3-phenyl-5,6,7,7a-tetrahydro-pyrazolo[1,5-d][1,2,4]oxadiazole